The Pharmaceutical Research and Manufacturers of America is intensifying efforts to halt implementation of the Inflation Reduction Act’s drug price negotiation program by teaming up with a medical provider group and a patient association to file a lawsuit in Texas. With multiple complaints now in various jurisdictions across the country, the drug industry could be in a stronger position to get one judge to grant a preliminary injunction that could slow down the implementation of the program.
PhRMA, the National Infusion Center Association and the Global Colon Cancer Association filed
